Supernus Pharmaceuticals, Inc. – Product Pipeline Review – Q2 2011 by GlobalMarketsDirect

VIEWS: 6 PAGES: 34

Supernus Pharmaceuticals, Inc. – Product Pipeline Review – Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, “Supernus Pharmaceuticals, Inc. - Product Pipeline Review - Q2 2011” provides data on the Supernus Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Supernus Pharmaceuticals, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Supernus Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Supernus Pharmaceuticals, Inc. - Brief Supernus Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Supernus Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Supernus Pharmaceuticals, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Supernus Pharmaceuticals, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Supernus Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Supernus Pharmaceuticals, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic class

More Info
									      Supernus Pharmaceuticals, Inc. – Product Pipeline
                    Review – Q2 2011
                                                                                          Reference Code: GMDHC1323CDB

                                                                                                Publication Date: JUL 2011




Supernus Pharmaceuticals, Inc. – Product Pipeline Review – Q2 2011                          GMDHC1323CDB / Published JUL 2011

© Global Markets Direct. This report is a licensed product and is not to be photocopied                                Page(1)
Supernus Pharmaceuticals, Inc. – Product Pipeline Review




Ta b le o f Co n te n ts
Table of Contents                                                                                                     2
List of Tables                                                                                                        3
List of Figures                                                                                                       4
Supernus Pharmaceuticals, Inc. Snapshot                                                                               5
    Supernus Pharmaceuticals, Inc. Overview                                                                           5
    Key Information                                                                                                   5
    Key Facts                                                                                                         5
Supernus Pharmaceuticals, Inc. – Research and Development Overview                                                    6
    Key Therapeutic Areas                                                                                             6
Supernus Pharmaceuticals, Inc. – Pipeline Review                                                                      8
    Pipeline Products by Stage of Development                                                                         8
    Pipeline Products – Monotherapy                                                                                   9
Supernus Pharmaceuticals, Inc. – Pipeline Products Glance                                                            10
    Supernus Pharmaceuticals, Inc. – Late Stage Pipeline                                                             10
         Phase III Products/Combination Treatment Modalities                                                         10
    Supernus Pharmaceuticals, Inc. Clinical Stage Pipeline Products                                                  11
         Phase I Products/Combination Treatment Modalities                                                           11
Supernus Pharmaceuticals, Inc. – Drug Profiles                                                                       12
    Epliga                                                                                                           12
         Product Description                                                                                         12
         Mechanism of Action                                                                                         12
         R&D Progress                                                                                                12
    SPN-538                                                                                                          13
         Product Description                                                                                         13
         Mechanism of Action                                                                                         13
         R&D Progress                                                                                                13
    SPN 802                                                                                                          14
         Product Description                                                                                         14
         Mechanism of Action                                                                                         14
         R&D Progress                                                                                                14
    SPN 808                                                                                                          15
         Product Description                                                                                         15
         Mechanism of Action                                                                                         15
         R&D Progress                                                                                                15
    SPN803                                                                                                           16
         Product Description                                                                                         16
         Mechanism of Action                                                                                         16
         R&D Progress                                                                                                16
Supernus Pharmaceuticals, Inc. – Pipeline Analysis                                                                   17
    Supernus Pharmaceuticals, Inc. – Pipeline Products by Therapeutic Class                                          17
    Supernus Pharmaceuticals, Inc. - Pipeline Products By Target                                                     18
    Supernus Pharmaceuticals, Inc. – Pipeline Products by Route of Administration                                    19
    Supernus Pharmaceuticals, Inc. – Pipeline Products by Molecule Type                                              20
Supernus Pharmaceuticals, Inc. – Recent Pipeline Updates                                                             21
Supernus Pharmaceuticals, Inc. – Company Statement                                                                   22
Supernus Pharmaceuticals, Inc. – Locations And Subsidiaries                                                          23




Supernus Pharmaceuticals, Inc. – Product Pipeline Review – Q2 2011                        GMDHC1323CDB / Published JUL 2011

©Global Markets Direct.. This report is a licensed product and is not to be photocopied                             Page(2)
Supernus Pharmaceuticals, Inc. – Product Pipeline Review



    Head Office                                                                                                           23
Financial Deals Landscape                                                                                                 24
    Supernus Pharmaceuticals, Inc., Deals Volume Summary, 2004 to YTD 2011                                                24
    Supernus Pharmaceuticals, Inc., Deals Summary By Region, 2004 to YTD 2011                                             25
    Supernus Pharmaceuticals, Inc., Deals Summary, 2004 to YTD 2011                                                       26
    Supernus Pharmaceuticals, Inc. Detailed Deal Summary                                                                  27
         Acquisition                                                                                                      27
         Supernus Pharmaceuticals Acquires Shire Laboratories                                                             27
         Venture Financing                                                                                                29
         SuperNus Pharma Raises $35 Million In Second Non-Dilutive Financing Round                                        29
         Supernus Pharmaceuticals Raises $45 Million In Series A Financing Round                                          30
         Depomed Enters Into Co-development Agreement With Supernus Pharmaceuticals                                       31
         Licensing Agreements                                                                                             32
         Supernus Pharmaceuticals Enters Into A Licensing Agreement With United Therapeutics                              32
Appendix                                                                                                                  33
    Methodology                                                                                                           33
         Coverage                                                                                                         33
         Secondary Research                                                                                               33
         Primary Research                                                                                                 33
         Expert Panel Validation                                                                                          34
    Contact Us                                                                                                            34
    Disclaimer                                                                                                            34




Lis t o f Ta b le s
Supernus Pharmaceuticals, Inc. – Pipeline by Therapy Area and Indication, 2011               
								
To top